Purchase Order 75N94025P00547

Award Date 9/1/25
Potential Completion Date 12/30/25
Potential Value $20K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $232,150 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian federal agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PROMETHION FLOW CELL PACKS, which are a key consumable component of Oxford Nanopore's PromethION sequencing platform. The contract has a period of performance through May 1, 2028. Oxford Nanopore Technologies Inc. is an established federal...
This is a $13,621 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of a NIDDK - Ligation Sequencing Kit and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is the prime contractor and has received multiple federal contract awards, including Indefinite Delivery...
This is a $21,835.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The purpose of the award is to provide a reagent needed by Shelise Brooks for the preparation of direct RNA libraries for sequencing on the Oxford Nanopore Promethion system in support of the Collins NF_Isletbetacells project led by Dr. Mike Erdos at NHGRI. The contract...
This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This is a $24,950 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a PROMETHION SEQUENCING INSTRUMENT AND REAGENT STARTER PACKAGE, with a performance period ending on May 21, 2026. Oxford Nanopore Technologies Inc. is the prime contractor and there are no subcontractors mentioned. The contract is not...
This firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization. The $10,928.00 award is for the delivery of Oxford Nanopore's DNA sequencing flow cells and reagents to support long-read sequencing activities at the agency's DNA Sequencing Core. The contract has a completion date of November 7, 2023 and does not utilize any...
This is a $161,638 firm-fixed-price purchase order awarded by the Northeast Area division of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of ROSEN - Oxford Nanopore FLO-PRO002 Promethion Flow Cell Packs, which are consumable supplies for Oxford Nanopore's PromethION DNA/RNA sequencing platform. The contract has a completion date of September 14, 2022 and does not have a set-aside designation....
This federal contract award, valued at $21,835.00, was issued by the National Human Genome Research Institute (NHGRI) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of 8 packs of 4 PROMETHION flow cells, which are consumable components used in Oxford Nanopore's genomic sequencing instruments. The contract does not have a set-aside designation and is a firm fixed-price purchase order, with an ultimate completion date of...
This federal contract award, valued at $21,835.00, was issued by the National Human Genome Research Institute (NHGRI) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the procurement of 8 packs of 4 PROMETHION flow cell packs (RNA), a product used in next-generation genomic sequencing. The contract has a firm fixed price and an ultimate completion date of November 14, 2025. Oxford Nanopore Technologies Inc. is a prime contractor that...
This firm-fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the procurement of 8 packs of 4 PROMETHION flow cells for RNA sequencing. This appears to be part of a larger Indefinite Delivery Vehicle (IDV) that Oxford Nanopore has with the NHGRI, as the company has...

This firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Oxford Nanopore Technologies, Inc., a foreign-owned, for-profit biotechnology company. The $19,965.00 award is for the delivery of Promethion flow cell packs and related sequencing reagents. This contract has an ultimate completion date of December 30, 2025 and does not utilize any set-aside designations. Oxford Nanopore Technologies provides advanced genomic sequencing equipment, consumables, and associated services to various federal agencies, supporting initiatives such as infectious disease tracking, agricultural genomics, and COVID-19 detection. The company holds several significant federal Indefinite Delivery Vehicles with agencies like the Defense Health Agency and USDA, which facilitate streamlined procurement of their specialized sequencing technologies across government research programs.

Generated 8/30/25, 10:06 AM